BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Bolder BioTechnology, Inc. 

4056 Youngfield Street

Wheat Ridge  Colorado  80033  U.S.A.
Phone: 303-420-4420 Fax: 303-420-4426


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Bolder BioTechnology, Inc. Announces Publication of Data Demonstrating Utility of the Company's Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury 8/30/2012 12:01:34 PM    More...
Bolder BioTechnology, Inc. Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants 11/4/2010 6:53:13 AM    More...
Bolder BioTechnology, Inc. Announces $600,000 Grant from National Institutes of Health (NIH) to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome 8/18/2010 11:34:54 AM    More...
Bolder BioTechnology, Inc. Receives $1.2 Million National Institutes of Health (NIH) Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease 9/17/2009 11:24:53 AM    More...
Bolder BioTechnology, Inc. Receives $1.9 Million National Institutes of Health (NIH) Grant to Continue Development of Long-Acting Growth Hormone Product 12/17/2008 7:47:41 AM    More...
Bolder BioTechnology, Inc. Receives $1.6 million National Institutes of Health (NIH) Grant to Continue Development of Multiple Sclerosis Drug 10/15/2008 11:28:41 AM    More...
Bolder BioTechnology, Inc. Awarded National Institutes of Health (NIH) Phase I SBIR Grant To Develop Bioscavenger Protein For Detoxifying Nerve Agents 10/19/2005 5:13:19 PM    More...
Bolder BioTechnology, Inc. Receives U.S. Patent For Process Used To Manufacture Proprietary Second-Generation Protein Pharmaceuticals 10/19/2005 5:12:36 PM    More...
Bolder BioTechnology, Inc. Awarded National Institutes of Health (NIH) Grant To Develop Novel Arthritis Treatment 10/19/2005 5:12:31 PM    More...
Bolder BioTechnology, Inc. Receives National Institutes of Health (NIH) Grant For Preclinical Development Of Proprietary Erythropoiesis-Stimulating Protein 10/19/2005 5:12:16 PM    More...
12